Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Rheumatoid arthritis Age: Adult |
Dose: Oral – 15 mg Frequency: once daily Note: single dose |
|
Indication: Ankylosing spondylitis Age: Adult |
Dose: Oral – 15 mg Frequency: once daily Note: single dose |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Juvenile rheumatoid arthritis Age: Child: greater than 2 years |
Dose: Oral – 0.125 mg/kg Frequency: once daily Note: Max: 7.5 mg daily |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment: Mild to moderate |
Dose: Not specified Note: No dosage adjustment needed |
|
Condition: Renal impairment: Severe |
Dose: Not specified Note: Not recommended |
Administration
- Can take with/without food
- Regular timing
Side Effect
- Indigestion (3.8-9.5%)
- Upper respiratory infection (Less than 8.3%)
- Headache (2.4-8.3%)
- Diarrhea (1.9-7.8%)
- Nausea (2.4-7.2%)
- Abdominal pain (1.9-4.7%)
- Edema (0.6-4.5%)
- Anemia (Less than 4.1%)
- Dizziness (1.1-3.8%)
- Constipation (0.8-2.6%)
- Angina (Less than 2%)
- Congestive heart failure (Less than 2%)
- Decreased platelet aggregation
- purpuric disorder (Less than 2%)
- Gastrointestinal (GI) hemorrhage (Less than 2%)
- GI perforation
- GI ulcer (Less than 2%)
- Hepatitis (Less than 2%)
- Hypertension (Less than 2%)
- Inflammatory disorder of digestive tract (Less than 2%)
- Myocardial infarction (Less than 2%)
- Vomiting (Less than 3%)
- Anaphylactoid reaction
- Angioedema
- Fever
- Asthma
- bronchospasm
- Cerebrovascular accident
- Erythema multiforme
- erythroderma
- Immune hypersensitivity reaction
- Interstitial nephritis
- renal failure
- Jaundice
- liver failure
- Stevens-Johnson syndrome
- Tinnitus
- hearing loss
- Toxic epidermal necrolysis
- Stevens Johnson syndrome
- thrombocytopenia
- interstitial nephritis and idiosyncratic liver abnormality
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Aspirin, Warfarin
|
Increased risk of severe GI effects
|
|
ACE Inhibitors (Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Fosinopril, Quinapril, Perindopril), Angiotensin II receptor antagonists
|
May antagonise antihypertensive effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe hepatic impairment
|
Risk of liver toxicity
|
|
Bleeding disorders
|
Risk of hemorrhage
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store Meloxicam tablet in a cool & dry place and away from light. Store Meloxicam suppository below 25˚C protected from light and moisture.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.